Quorum Review IRB Launches Program for Phase I Clinical Trials
Quorum Review IRB is introducing a comprehensive program that supports the needs of Phase I Healthy patients.
Quorum Review IRB is introducing a comprehensive program that supports the needs of Phase I Healthy patients. With this new Phase I Program, a study can be ready to enroll participants within a few days of submitting their materials. Quorum’s new program also provides alternatives in the review of recruitment materials. It can also conditionally approve recruitment materials before the protocol review is finalized, it allows a proactive plan for deployment.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025